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Abstract. Background: Psoriasis is a chronic inflammatory disease of the 
skin that characterized by firmly bound erythema plaques covered in thick 
squama and caused by multiple abnormalities of genetic, biochemical, 
immunologic, vascular with further severed by various other factors such 
as psychology, drugs, smoking, and alcohol consumption. Several studies 
revealed that psoriasis can increase the risk of cardiovascular diseases such 
as hypertension, however, the underlying pathophysiological mechanism 
has not been confirmed yet. This mechanism is probably attributed to 
increased levels of angiotensin-converting enzyme produce angiotensin II 
that regulates vascular tonus, endothelin-1 (ET-1) has been considered an 
important role in that vasoconstrictor proteins are potent, and increased 
plasma renin activity has been reported in patients with psoriasis. Purpose: 
In order to figure out the relationship between psoriasis and hypertension 
in psoriasis patients at the Outpatient Unit -RSI Jemursari Surabaya.   
Methods: This study was observational analytics with cross sectional study 
design in 28 psoriasis patients at Outpatient Unit-RSI Jemursari Surabaya 
during 2017-2019, using total sampling technique. Secondary data from 
medical records was collected and further analyzed with spearman 
correlation tests.  
Result: The obtained significance value is 0.000 (p < 0.05), which represent 
a significant relationship between hypertension and psoriasis. the 
correlation coefficient is 0.757, which indicates the strength of a strong 
relationship between two variables.  
Conclusion: There is a significant association between Psoriasis and 
Hypertension.  
  
Psoriasis is a chronic inflammatory disease of 
the skin that characterized by the presence of 
firmly bound erythema plaque covered in thick 
skuama (Pratiwi & Damayanti, 2018). Psoriasis 
is caused by multiple abnormalities of genetic, 
biochemical, immunology, vascular as well as 
exacerbated by various other factors such as 
psychology, drugs, smoke, and alcohol (Saurat 
et al., 2010). Psoriasis is a common disease in 
the world with 2-3% of the average prevalence 
value range of 0.09% to 11.43%. Approximately 
100 million people in the world experience 
psoriasis according to this data (WHO, 2016). 
Meanwhile, the Indonesian psoriasis patients 
prevalence reaches 2.5% of the population and 
from such prevalence, there still many who 
have not received medical treatment (Sugito, 
2008). 
Several studies revealed that psoriasis 
may increase the risk of cardiovascular diseases 
such as hypertension (Cantika et al., 2012). The 
underlying pathophysiological mechanism has 
not yet been determined, but can be associated 
with elevated levels of angiotensin-converting 
enzyme, endothelin-1 (ET-1), and rennin. Adi-
pose tissue as the main source of angiotensi-
nogen, which is then converted into angioten-
sin II as a vascular tonus regulator (Armstrong 
et al., 2011). Endothelin-1 has been considered 
Jurnal Kesehatan Islam Volume 10 Nomor 2 Tahun 2021 
73 
 
an important role in that vasoconstrictor pro-
teins are potent and produced by several diffe-
rent cell types, including keratinocytes 
(Salihbegovic et al., 2015). 
A well known understanding of the 
impact and relation mechanism between pso-
riasis and increased risk of cardiovascular di-
sease, especially hypertension, can help the 
therapies development that improve the prog-
nosis of these two comorbid diseases.  
  
METHODS  
This research was observational analytics 
with cross sectional approach. The research 
was conducted at Jemursari Islamic Hospital 
Surabaya. Secondary data from the medical 
records of psoriasis patients was collected in 
June 2020. The research samples was selected 
from psoriasis patients that treated at Jemur-
sari Islamic Hospital Surabaya in the period 
2017 to 2019 with various criteria such as 
various types of psoriasis degrees, age > 14 
years, and patient localization history.  
The sample selection result obtained 28 
patients who met the inclusion and exclusion 
criteria. The free variable in this study was 
psoriasis, while the bound variable was hyper-
tension. Data management and analysis is 
performed using spss computer data proces-
sing program and Spearman’s statistical test 
with significant value at less than α (α  0.05).  
  
RESULTS 
The research data sample was secondary 
data in the form of electronic medical record 
data of psoriasis patients that obtained from 
the medical record unit at RSI Jemursari Sura-
baya. 
 
Table 1 Frequency Distribution of Blood Pres-
sure Picture in Psoriasis Patients at 
RSI Jemursari Surabaya 2017-2019 
Blood pressure category Number of cases Percentage 
Normal 4 14,3 
Prehypertensive 17 60,7 
1st stage hypertension 5 17,9 
2nd stage hypertension 2 7,1 
Total 28 100,0 
Source: Medical Record data at RSI Jemursari in 
2017-2019. 
 
Table 1 shows that 17 cases (60.7%) 
patients had blood pressure that included in 
prehypertension. Whereas, a small percentage 
of patients come into 1st stage hypertension 
category (17.9%), normal blood pressure 
(14.3%) and 2nd stage hypertension (7,1%). 
 
Table 2 Frequency Distribution of PASI Score 
Degree (Score Psoriasis Area and 
Severity Index) in Psoriasis patients at 
RSI Jemursari Surabaya 2017-2019 
PASI score degree Number of cases Percentage 
low 19 60,7 
moderate  5 25 
height  4 14,3 
Total 28 100 
Source: RSI Jemursari Medical Record 2017-
2019. 
 
Table 2 shows that 19 cases (60.7%) of 28 
cases is low PASI score degrees, while 5 cases 
(25%) is moderate degree patients, and only 4 
cases (14.3%) is height PASI score degree. 
 
Table 3 Hypertension Relationship with Pso-




PASI score degree 
Total number 
(precentage) 
low moderate height  
Normal 4 0 0 4 (14,3) 
Prehypertension 15 1 1 7 (60,7) 
1st stage hypertension 0 4 1 5 (17,9) 
2nd stage hypertension 0 0 2 2 (7,1) 
Total 19 5 4 100 
Source: RSI Jemursari Medical Record 2017-
2019. 
 
Table 3 shows that the most cases is 
psoriasis with low degrees, each of the 4 cases 
had normal blood pressure and 15 cases with 
Pre-hypertension. For a small percentage of 
cases psoriasis is height degree, each of 1 case 
had Pre-hypertension category, 1 case had 1st 
stage hypertension category, and 2 patients 
belonged to the category of 2nd stage hyper-
tension. The results of statistical tests using 
Spearman showed that the significance value 
obtained p 0.000, there is a significant relation-
ship between psoriasis and hypertension. The 
Correlation Coefficient result is 0.757, indicat-
ing that there is a strong strength of the 
relationship between the two variables.  




This study determined blood pressure 
into 4 categories; (a) normal category has less 
than 120 on systolic and less than on diastolic 
80 mmHg blood pressure, (b) prehypertension 
category has 120-139/80-89 mmHg systolic/ 
diastolic blood pressure, (c) 1st stage hyperten-
sion has 140-159/90-99 mmHg systolic/diasto-
lic blood pressure, (d) 2nd stage hypertension 
has ≥ 160/ ≥ 100 mmHg systolic/diastolic blood 
pressure. This study revealed that 14.3% pa-
tients had normal blood pressure category, 
60.7% blood pressure patients had prehyper-
tension category, 17.9% patients had 1st stage 
hypertension blood pressure category, and 
7.1% patients had 2nd stage hypertension 
blood pressure category. Hence, most of the 
patients that become a research study subject 
suffering from prehypertension.  
One of the techniques that used to mea-
sure psoriasis severity is Psoriasis Area and 
Severity Index (PASI) score (Permatasari, 2015). 
PASI score is a method to measure the severity 
of the disease. According to the Australian 
Government Therapeutic Goods Administration 
the severity of the disease is divided into 3 ca-
tegories namely < 10 (low), 10-20 (moderate), > 
20 (height). PASI score calculate the affected 
area with severity level of erythema, infiltration 
thickness, and skuama. This method is practical 
and fast, however, it has high intra-observer 
variability and little research focus on its validity 
and sensitivity.  
This study show that 19 patients (60.7%) 
had low degree of psoriasis, 5 patients (25%) 
had moderate psoriasis, and 4 patients (14.3%) 
with height degree of psoriasis. However, the 
results of the study are different from the re-
sults of studies conducted by Budini et al., 2014 
in 25 patients, obtained the severity of low di-
sease found in 4 patients, moderately 10 pa-
tients and height 11 patients, where more pa-
tients with height degrees, than with psoriasis 
patients with low or moderate (Budini et al., 
2014). 
The results of this study was different 
with the research study which conducted by 
Budianti et al., 2019  most of the patients who 
came to polyclinics were included in severe 
psoriasis with a BSA/PASI score of > 10 which 
amounted to 15 people (47%). The number of 
patients with severe severity is more common 
because RSCM is a national tertiary referral 
service hospital that accepts referral patients 
from various primary and secondary services in 
Indonesia. Cases of psoriasis are low and 
moderate, more widely handled in primary and 
secondary services. Moderate degree psoriasis 
is the second most after height psoriasis, with a 
BSA/PASI score of 310, and a patient count of 9 
people (28%), followed by low psoriasis with a 
BSA/PASI score of < 3% of 8 people (25%) 
(Budianti et al., 2019). Researchers argue that 
the possible difference in results is due to the 
level of research location services as a tertiary 
hospital so that patients who come to the hos-
pital are patients with moderate-height symp-
toms.  
The results of statistical tests using 
Spearman showed that the significance value 
obtained was 0.000 (p < 0.05) that refer to a 
significant relationship between Hypertension 
and Psoriasis. The Correlation Coefficient is 
0.757, this suggests that hypertension and pso-
riasis have a strong relationship. Hypertension 
is determined according to psoriasis patients’ 
blood pressure that recorded in the patient's 
medical record while psoriasis diagnosed by a 
specialist in skin and venereal diseases and 
recorded in patient's medical record data. This 
research study exhibit that heavier the psoriasis 
degree along with blood pressure increment. 
Furthermore, this research study result was 
accordance with Cohen et al. (2010) (11).  
Budini (2014) conducted study about 
TNF-α skin lesions with the severity of psoriasis. 
It revealed that the higher the level of TNF-α 
skin lesions followed with the severity of the 
disease that determined with the correlation 
coefficient value of 0.587 with p = 0.002 (Budini 
et al., 2014). TNF-α was related to be hyperten-
sion in psoriasis, where in hypertension can 
caused hyperproliferation of keratinocytes in 
psoriasis TNF-α (Budini et al., 2014). Keratino-
cyte hyperproliferation produces endothelin-1, 
which further narrowing blood vessels and in-
creasing blood pressure that can caused hyper-
tension (Salihbegovic et al., 2015). Hence, the 
increasing TNF-α can caused blood pressure. 
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The exact pathophysiological mecha-
nisms underlying psoriasis and hypertension 
are likely caused by adipose tissue in psoriasis 
patients that serves as the primary source of 
angiotensinogen, which is then converted into 
angiotensin II. Angiotensin II can increase salt 
retention by the kidneys, and may also stimula-
te the proliferation of T-cells (Armstrong et al., 
2011). Angiotensin II, a product of angiotensin-
converting enzyme (ACE) that regulates vascu-
lar tonus and stimulates the release of pro-in-
flammatory cytokines. Increased plasma renin 
activity has been reported in patients with pso-
riasis. The relationship between psoriasis and 
hypertension can also be associated with endo-
thelin-1 production, which is produced by 
keratinocytes as an autocrine growth factor 
(Cohen et al., 2010). Bonifati et al., (2007) 
reported that endothelin-1 increased in sera 
skin and lesions of psoriasis patients, compared 
to control. Endothelin-1 levels correlated with 
the severity of psoriasis (Bonifati & Berardesca, 
2007). Endothelin-1 is a potent vasoconstrictor 
and can cause hypertension in psoriasis pa-
tients. 
The pathophysiological mechanisms on 
psoriasis and hypertension were probably cau-
sed by adipose tissue in psoriasis patients. Adi-
pose tissue is the primary source of angioten-
sinogen, that further converted into angioten-
sin II.  
Angiotensin II not only increases salt re-
tention in kidneys but also stimulates T-cells 
proliferation (Armstrong et al., 2011). Angioten-
sin II is an angiotensin-converting enzyme (ACE) 
product that controls blood vascular tone and 
stimulates pro-inflammatory cytokines release. 
the observation on psoriasis patients showed 
that plasma renin activity was increased. Pso-
riasis and hypertension were associated with 
endothelial-1 production which is produced by 
keratinocytes as an autocrine growth factor 
(Cohen et al., 2010). Bonifati et al., (2007) 
reported that endothelin-1 was increased in 
sera skin and lesions in psoriasis patients com-
pared to control. Endothelin-1 levels were 
correlated with psoriasis severity (Bonifati & 
Berardesca, 2007). Endothelin-1 is a potent 
vasoconstrictor and hypertension causes in 
psoriasis patients. 
This research result was align with Cohen 
et.al (2010) that exhibit endothelin-1 levels has 
correlation with psoriasis the severity of. En-
dothelin-1 is a potent vasoconstrictor and hy-
pertension causes in psoriasis patients. There-
fore, the endothelin-1 increment along with 
blood pressure. This study results revealed that 
psoriasis severity was increased with blood 
pressure in psoriasis patients.  
  
CONCLUSION  
The results of the study conducted at RSI 
Jemursari Surabaya using research data as 
many as 28 medical records of psoriasis pa-
tients in 2017-2019 were concluded that there 
is a significant relationship between psoriasis 
and hypertension, with the strength of a strong 
relationship. Cardiovascular disease has been 
widely proven to be one of the comorbidities in 
psoriasis that needs to be considered. Various 
studies have shown an association of inflam-
matory processes in the pathogenesis of these 
two diseases. Every clinician needs to be aware 
and provide therapy for comorbid diseases. 
Patients also need to be educated to increase 
physical activity and reduce alcohol and ciga-
rette consumption.  
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